Amarin reported $1.04B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
Aerie Pharmaceuticals AERI:US $ 355.53M 7.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amarin AMRN:US $ 1044.99M 54.74M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
AstraZeneca AZN:LN 73641M 8715M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Epizyme EPZM:US $ 352.55M 54.16M
Esperion Therapeutics ESPR:US $ 280.46M 1.86M
GlaxoSmithKline GSK:LN 77011M 1068M
Halozyme Therapeutics HALO:US $ 1025.86M 59.28M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
JAZZ PHA JAZZ:US $ 13212.99M 6456.52M
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NOVN:VX SF 124015M 2263M
Teva Pharmaceutical Industries TEVA:US $ 49195M 191M